M. Hochstenbag
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Oncology top 10%
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Diagnosis and Treatment 10
- Lung Cancer Treatments and Mutations 9
- Oncology 14
- Lung Cancer Research Studies 12
- Co-authors
- A. Twijnstra (3 shared papers)Philippe Lambin (10 shared papers)Madelon Pijls-Johannesma (3 shared papers)J. T. Wilmink (1 shared paper)Anita A.M. Botterweck (2 shared papers)Anne‐Marie C. Dingemans (8 shared papers)Wiel Geraedts (5 shared papers)Jean Simons (4 shared papers)
- Journals
- Lung Cancer (8 papers)Annals of Oncology (4 papers)European Journal of Cancer (3 papers)Radiotherapy and Oncology (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
M. Hochstenbag
26 papers receiving 548 citations
Peers
Comparison fields: 5 of 46
- Pulmonary and Respiratory Medicine 429
- Oncology 284
- Otorhinolaryngology 42
- Radiation 53
- Radiology, Nuclear Medicine and Imaging 77
Countries citing papers authored by M. Hochstenbag
This map shows the geographic impact of M. Hochstenbag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hochstenbag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hochstenbag more than expected).
Fields of papers citing papers by M. Hochstenbag
This network shows the impact of papers produced by M. Hochstenbag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hochstenbag. The network helps show where M. Hochstenbag may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Hochstenbag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 143 | |
| 2 | 2000 | 108 | |
| 3 | 2010 | 80 | |
| 4 | 2003 | 52 | |
| 5 | 2015 | 42 | |
| 6 | 2007 | 40 | |
| 7 | 2023 | 19 | |
| 8 | 1996 | 11 | |
| 9 | 2005 | 11 | |
| 10 | 2021 | 11 | |
| 11 | 2005 | 7 | |
| 12 | A novel time factor, the SER (Start of any treatment and the End of Radiotherapy), is predictive for local control and survival in a systematic overview of combined chest radiotherapy and chemotherapy for limited stage small cell lung cancer | 2004 | 4 |
| 13 | 2011 | 3 | |
| 14 | 2022 | 3 | |
| 15 | 2009 | 3 | |
| 16 | 2005 | 2 | |
| 17 | Sorafenib in pretreated patients with advanced non-small lung cancer harbouring a K-ras mutation | 2009 | 2 |
| 18 | 2011 | 2 | |
| 19 | Selective mediastinal node irradiation on basis of the FDG-PET scan in patients with NSCLC is safe: results of a prospective clinical study | 2004 | 1 |
| 20 | 1996 | 1 |
About M. Hochstenbag
M. Hochstenbag is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery and Neurology, having authored 27 papers that have together received 552 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (12 papers), Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (9 papers), Myasthenia Gravis and Thymoma (4 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Medical Imaging Techniques and Applications (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (429 citations), Oncology (284 citations), Otorhinolaryngology (42 citations), Radiation (53 citations) and Radiology, Nuclear Medicine and Imaging (77 citations). M. Hochstenbag has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include A. Twijnstra, Philippe Lambin, Madelon Pijls-Johannesma, J. T. Wilmink, Anita A.M. Botterweck, Anne‐Marie C. Dingemans, Wiel Geraedts, Jean Simons, Cordula Pitz and Rinus Wanders. Their work appears in journals such as Lung Cancer, Annals of Oncology, European Journal of Cancer, Radiotherapy and Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.